DSCSA Compliance: What Pharma Needs From a 3PL

If you manufacture, import or distribute prescription drugs in the United States, the Drug Supply Chain Security Act has changed what you can ask of a logistics provider. Storage and shipping are the easy part. The harder requirement is that your 3PL can receive, hold and pass along serialized transaction data without breaking the chain.

Here is what DSCSA asks of trading partners, where a third-party logistics provider fits, and the questions to ask before you move pharmaceutical inventory into anyone’s warehouse.

What DSCSA requires, in brief

DSCSA was enacted in 2013 to build an electronic, interoperable system for tracing prescription drugs through the U.S. supply chain. It phased in over roughly a decade, and the end state has three practical components:

• Serialization. Packages carry a unique product identifier — a 2D data matrix encoding the NDC, serial number, lot and expiration date.
• Interoperable electronic tracing. Transaction information and transaction statements move electronically between trading partners, and must be exchanged at the package level.
• Verification and response. Trading partners must be able to verify a product identifier, quarantine and investigate suspect or illegitimate product, and respond to requests within defined timeframes.

FDA granted staged exemptions after the original compliance date to let the industry stabilize, with different end dates for manufacturers, wholesale distributors, dispensers and small dispensers. Those windows have largely closed. Because FDA guidance in this area has been revised more than once, confirm your own current obligations directly with FDA rather than relying on a summary.

Where a 3PL sits in the DSCSA framework

DSCSA treats a third-party logistics provider as a distinct category. A 3PL provides storage and distribution services on behalf of a manufacturer or distributor but does not take title to the product. That distinction has real consequences:

• Because the 3PL never owns the drug, it is generally not the party generating transaction information for a sale — the owner is.
• A 3PL is nonetheless a trading partner and must be an authorized one, which means holding the required state licensure and meeting federal reporting obligations.
• The 3PL must be able to handle serialized product physically and informationally: receive it, store it, verify identifiers when required, and support investigations of suspect product.

In practice, this means you cannot treat a pharma 3PL like a general warehouse with a thermometer.

Licensure and reporting

Third-party logistics providers must be licensed by the state or states in which they operate, or by FDA where a state licensing program is not in place, and must report facility information annually. Ask any prospective provider for:

• Their 3PL license number and the states it covers
• Confirmation of their annual FDA reporting status
• Their designated responsible person for regulatory matters

If a provider cannot produce this quickly, that is your answer.

The operational requirements that follow

Serialization-capable receiving

Scanning a case barcode is not enough. The facility needs scanners and a system that can read 2D data matrix codes, capture serial numbers, and aggregate them to case and pallet level so that shipping a case does not require opening it to know what is inside.

Data exchange

Transaction data typically moves via EPCIS. Ask which standard version the provider supports, how data is exchanged with your systems, and how long records are retained — DSCSA requires trading partners to keep transaction information and statements for six years.

Quarantine capability

Suspect, illegitimate, recalled and expired product must be physically segregated and system-locked so it cannot be picked. A designated, controlled quarantine area is a basic requirement, not a nice-to-have.

Temperature control and monitoring

Most pharmaceutical product has defined storage conditions, and controlled room temperature is still a specification, not a default. You need continuous monitoring, alarming, documented excursion procedures, and calibration records. See our temperature-controlled storage capabilities and our overview of pharmaceutical warehousing.

FEFO picking and expiration control

Pharmaceutical inventory has to move first-expired-first-out, enforced by the system rather than by the picker’s judgment. If you are unfamiliar with the distinction, our comparison of FIFO, LIFO and FEFO rotation explains why FEFO is the only defensible method here.

Security and access control

Controlled access to the pharma area, camera coverage, visitor logging, and background-checked personnel. Diversion risk is the reason these controls exist, and auditors look at them closely.

A due-diligence checklist

Before you sign, ask a prospective provider to walk you through:

1. Current 3PL licensure and the states covered
2. Whether they can receive and ship serialized product at package and case level today, with a live demonstration
3. Which EPCIS version they support and how the connection to your system would work
4. Their written procedures for suspect product investigation and quarantine
5. Temperature mapping and monitoring documentation for the storage area you would occupy
6. Recall execution procedure and the last time they ran one, real or mock
7. Their record retention practice and how you would retrieve records during an audit
8. Whether they have been inspected by FDA or a state board, and what came of it

Adjacent categories

Medical devices, over-the-counter products and dietary supplements are not covered by DSCSA, but they often share a facility, a temperature requirement and a customer base with prescription product. If your portfolio spans categories, our note on medical device warehousing in Miami covers the parallel expectations there.

Contact our team to discuss how your pharmaceutical inventory and data requirements would map to our Miami facility.

Frequently asked questions

Does DSCSA apply to over-the-counter drugs?

No. DSCSA applies to prescription drugs in finished dosage form intended for human use. Over-the-counter products, medical devices and dietary supplements fall outside its scope, though they carry their own regulatory requirements.

Is my 3PL responsible for my DSCSA compliance?

No. As the product owner you remain responsible for your own obligations, including generating and passing transaction information. Your 3PL must be an authorized trading partner, licensed, and operationally capable of handling serialized product — but their compliance does not substitute for yours.

How long must DSCSA records be kept?

Trading partners are required to maintain transaction information and transaction statements for six years from the date of the transaction. Confirm the retention arrangement with your logistics provider in writing, including how you would access records if the relationship ended.